When putting together a submission for study involving an investigational drug, please make sure the submission includes the related investigator’s brochure (the IB). The IB contains important safety information about the drug the IRB will need to see before it can review the study. All investigational drugs will have an IB provided by the study sponsor. If it looks as though you haven’t received one, please track it down and upload it to CLARA before the study makes it to the IRB for review. The IRB is unable to review investigational drug studies without the IB information.